Clene Inc.

US$3.95As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CLNNHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR (37.81%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 1.06
PE TTM —
TSR TTM (68.40%)
Mkt cap US$56.15M
ROIC (158.57%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.78
(4.37%)
(44.74%)
Hold 12|4|5|4|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.07
0.07
0.06
0.06
12.71%
5.90%
5.51%
(0.99%)
Revenue$M
4.421
4.341
4.251
4.379
15.31%
8.43%
0.54%
(1.28%)
Peers (US$56.15M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.696
0.644
0.543
EBIT/Intx
0.359
0.064
0.080
Own earn%
126.33
68.43
63.65
Sh yield%
56.29
26.90
26.58
Owners
Insiders/Inst%
14.01
89.25
Short interest%
0.90
SBC / revenue%
5.32
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
20–23
$1 testx
—
Incr. ROIC%
2